A blind man and a double amputee planted 10,000 trees. What’s your excuse?

“I am his hands. He is my eyes.”

Jia Haixa talks of his symbiotic relationship with his friend Jia Wenqi — a double amputee. The pair work together to plant trees in Yeli village, just outside of Shijiazhuang city, northern China.

Losing his sight in one eye to congenital cataracts, and later his right eye in a work-related accident, Jia Haixa is completely blind. The friends approached the local government and leased a 7.5 acre stretch of land along the riverbank. They hope to transform it by planting 1,000 trees every year, and have been doing that for a decade.

Planting the trees helps them to earn money, having both struggled to find work individually due to their handicaps. They also hope to benefit future generations with their environmental efforts.

Fortunately, the local authorities allow them to live rent-free, which is a great gesture given their poor living conditions.

9 Inspiring quotes from some of the most successful women in history.

It seems recently that a lot is coming up dealing with women having issues with equality in the workplace.

While in some businesses it is difficult to stand out among the testosterone, there have been women breaking through and surpassing their male counterparts throughout history.

If you feel that your gender is an obstacle that will hold you back, read these quotes, spoken by some of the most successful women in history.

Embrace the power and confidence their words emanate! No matter who you are, you can succeed!



Michelle Obama



Maya Angelou






Lucille Ball



Eleanor Roosevelt



Coco Chanel



Charlotte Gilman



Audrey Hepburn



Amelia Earheart

Night Vision Enhanced To Superhuman Levels Using Common Cancer Drug, Eye Drops

Chlorin e6, or Ce6, is a common component in cancer therapy and has recently been used in treating night blindness. Science for the Masses, a research group of curious “BioHackers,” were interested in what the chemical could do for those who already had perfect vision. The result was astounding and could affect the way we currently approach night vision enhancement.

Ce6 is a compound found mainly in deep-sea fish and sometimes used as a photosensitizer in laser-assisted cancer treatment. Ce6’s sensitivity to light has been observed to help thosewho are visually impaired; however, its effects on perfectly healthy human vision remained untested. That is, until about a month ago when Gabriel Licina, Jeffrey Tibbetts, and their science-hungry teammates decided to create their own night-vision experiment.

To start their venture into super-human abilities, the team first procured the Ce6 and mixed it into a saline solution which was then deposited into Licina’s eye. “It doesn’t really feel like anything,” Licina told Medical Daily. “It felt like eye drops.”

According to the paper on the experiment, afterward Licina was fitted with black sclera lenses to help reduce the amount of potential light from entering his eye. He also wore black sunglasses at all times, except during the vision experiments. After letting the solution set in his eye for about two hours, Licina and four controls went into a dark field to test how well the solution enhanced his eyesight in pitch blackness. As expected, Licina’s eyesight was significantly better than those who did not receive the solution. When asked to point out people standing in the dark woods, Licina was correct 100 percent of the time, while the controls only answered correctly about a third of the time, Mic reported.

“It’s actually really subtle … like dark becomes dim, nothing crazy like Riddick. Just like, ‘Oh, you can see better,” Licina said.

putting in the solutionAfter letting the solution set in his eye for about two hours, Licina and four controls went into a dark field to test how well the solution enhanced his eyesight in pitch blackness. Photo courtesy of Science of the Masses

Although the team waited two hours before beginning experiments, according to Licina’s paper, the effects could be felt within one hour and lasted for “many hours” after the application. The sunglasses were again put on Licina, who wore them until he awoke in the morning. As of 20 days following the experiments, Licina reported no residual effects.

While there were no major side effects reported in Science for the Masses’ experiment, the group used large precaution with their experimentation, and for a good reason. Ce6 by nature is meant to create free radicals when given the right wavelength, which in the right instances can destroy cancer and in the wrong can cause bodily damage. The small doses used by the team, however, are highly unlikely to cause damage.

The results from this initial experiment were exciting, but Science for the Masses explained that much more testing will need to be done in order to truly prove Ce6’s night vision enhancing abilities. The next step for the team is to accurately measure the changes to the eye and create concrete scientific evidence to their findings.

“The first thing was just getting it out there,” Licina said. “It’s just another piece in the big understanding of how things work.”

Source: Licina G, Tibbetts J. A Review on Night Enhancement Eyedrops Using Chlorin e6.Science for the Masses. 2015.

LifeVest ‘Wearable Defibrillator’ a Cost-Effective Bridge After ICD Removal for Infection

For patients who have undergone the successful removal of their implantable cardioverter defibrillator (ICD) because of an infection, the use of a wearable cardioverter defibrillator (LifeVest, Zoll) is a cost-effective treatment strategy for preventing sudden cardiac death (SCA) while patients wait for another device, according to a new analysis[1].

“The decision regarding when to reimplant must be individualized to each patient and clinical situation,” state Drs Christopher Healy and Roger Carrillo (University of Miami Miller School of Medicine, FL). “For many patients, continuous inpatient monitoring may be impossible or at least highly undesirable. The wearable cardioverter defibrillator is likely a cost-effective treatment modality for the prevention of SCA in a significant number of these at-risk patients.”

Writing in Heart Rhythm March 31, they note that a patient is typically given antibiotics for several weeks following the extraction of an infected device. If a second device is put in too soon, there is a risk of repeat infection. While the device is out, however, there is a risk of SCA. For the patient, continuous monitoring is impractical and, for the hospital, expensive.

In the present analysis, outpatient use of the wearable defibrillator cost $1805 more but resulted in better clinical outcomes compared with a strategy of discharging the patient home without a wearable or implanted defibrillator. Based on a 5.6% risk of sudden cardiac death within the first 2 months (4.0% risk within the first month), 0.089 life-years were gained with the wearable defibrillator, yielding an incremental cost-effectiveness ratio (ICER) of $26 436 per quality-adjusted life-year (QALY) gained.

As with all economic analyses, the researchers made some assumptions. Their base-case scenario assumed the wearable defibrillator was 84.5% effective in terminating potentially fatal ventricular tachyarrhythmias. If the efficacy of the defibrillator increased to 95%, the ICER was as low as $15 392/QALY. If efficacy declined below 69%, the wearable defibrillator would no longer be considered cost-effective as it would exceed $50 000/QALY.
The wearable defibrillator was also cost-effective as long as the time to reimplantation of the replacement ICD was at least 2 weeks.

Additionally, researchers report the wearable device was cheaper than discharging patients to a nursing facility or leaving them in the hospital, and also had better clinical outcomes. As a result, the wearable defibrillator was considered a “dominant” strategy against these two treatment options.

Simple Intravenous Fluid Could Save Many Ebola Patients, Specialists Say

Simple intravenous fluid drips could save the lives of many West African Ebola patients, but are being neglected because of a perception that there is no effective treatment for the disease, specialist doctors said on Friday.

“Ebola treatment centers must be more than just a setting for quarantine,” Ian Roberts of the London School of Hygiene and Tropical Medicine and Anders Perner of Copenhagen University wrote December 6 in The Lancet. “Patients will be reluctant to attend treatment centers unless the care they receive … is superior to the care provided by family members.”

West Africa’s Ebola epidemic, by far the largest on record, has killed more than 6,000 of the 17,000 or so people infected so far, according to the World Health Organization. Guinea, Liberia and Sierra Leone account for all but 15 of the deaths.

But many patients are probably dying not from the disease’s signature hemorrhaging, but from extreme dehydration and electrolyte depletion caused by nausea, vomiting and diarrhea, the scientists wrote.

The fact that there is no proven vaccine or drug cure has led to the “widespread misconception” in the worst-hit countries that no treatment is effective, Roberts and Perner said.

“Whereas many patients … receive oral rehydration and some electrolyte substitution, the use of intravenous fluids and electrolytes varies, and it is likely that many patients die from deficiencies in fluid volume and electrolytes.”

Does Red Meat Consumption Cause Cancer?